Data as of Oct 17
| +0.27 / +4.09%|
The 7 analysts offering 12-month price forecasts for LeMaitre Vascular Inc have a median target of 11.00, with a high estimate of 11.50 and a low estimate of 10.00. The median estimate represents a +60.12% increase from the last price of 6.87.
The current consensus among 7 polled investment analysts is to Buy stock in LeMaitre Vascular Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.